JoAnne
McLaurin

Dr. McLaurin is Director and Senior Scientist within Biological Sciences Platform at Sunnybrook Research Institute, Canada Research Chair Tier 1 in Alzheimer’s disease Therapeutics, Lead Theme 1 Preclinical Research in Dementia for the Canadian Consortium on Neurodegeneration and Aging and a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.  She is recognized for a body of work on the detrimental effects of Aβ accumulation and benefit of reduction of Aβ using small molecules.  Dr. McLaurin’s present focus is translational research to understand factors impacting risk and progression of age-related cognitive decline.  Specifically, the discovery of much-needed treatments for Alzheimer’s disease and dementia.

Her successful research program demonstrates Dr. McLaurin’s ability to identify target molecules, to develop lead compounds through preclinical development and to translate this knowledge to appropriate international stakeholders.